Hansa Biopharma AB
556734-5359ActiveDeveloping innovative immunomodulating therapies for rare immunologic diseases.
Biopharmaceutical Companyhansabiopharma.com
Yleiskatsaus
- 100–199
- Työntekijät
- 50–100milj SEK
- Liikevaihto
- 2007
- Perustettu
Avainpäättäjät
Hitto Kaufmann
Chief Scientific & Technology Officer
@hansabiopharma.com
Richard Philipson
Chief Medical Officer
@hansabiopharma.com
Brian Gorman
Chief Legal Officer and Corporate Secretary
@hansabiopharma.com
Evan Ballantyne
Chief Financial Officer
@hansabiopharma.com
+17 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Hansa Biopharma is a science-led biopharmaceutical company dedicated to empowering people living with rare immunologic diseases. They focus on developing innovative immunomodulating therapies designed to transform patient lives. The company leverages proprietary antibody-cleaving enzyme technology,...
CHIESI PHARMA AB